PDC and neoplasm: Exome sequencing demonstrated that this non-HM PDC shared a proportion of the mutations seen in 3 spatially distinct tumor tissue samples (T1, T2, T3) as well as the 41 truncal mutations found in all samples from the first and second recurrence of this patient.